Home›Companies›Biotech & Pharma›iOncologi

iOncologi, Inc.

Updated Oct 29, 2026·Latest SEC filing May 23, 2025·Suggest an edit

About iOncologi

iOncologi is a private company based in Gainesville, Florida. It has reported $3,250,000 raised in two offerings on Form D since March 2025. Its chief executive is Edgardo Rodriguez-Lebron.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 8, 2025May 23, 2025$250,000of $12.0M target3$83,333Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 18, 2025Mar 5, 2025$3,000,000fully sold17$176KDebt, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$3,250,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on iOncologi's Form D filed May 23, 2025.

PF
PK
Peter Kash
Director
DM
MF
Mona Flores
Director
EL
Edgardo Rodriguez-Lebron
CEO and director

Earlier filings also listed Michelle Mitchell (executive officer and director, last listed Mar 2025), Edgardo Rodriguez (chief executive officer and director, last listed Mar 2025) and Catherine Flores (director, last listed Mar 2025).

Sources

  1. SECiOncologi, Inc. filing history